Medicare Enrolled

Dr. Fabrizio Monge, M.D.

Pulmonary Disease · Punta Gorda, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
25086 OLYMPIA AVE, Punta Gorda, FL 33950
9412055300
In practice since 2006 (19 years)
NPI: 1972605434 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Monge from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Monge? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Monge

Dr. Fabrizio Monge is a pulmonary disease in Punta Gorda, FL, with 19 years in practice. Based on federal Medicare data, Dr. Monge performed 6,600 Medicare services across 4,441 unique beneficiaries.

Between the years covered by Open Payments, Dr. Monge received a total of $11,267 from 45 pharmaceutical and/or device companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Monge is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 2% volume in FL$ $11,267 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,600
Medicare services
Top 2% in FL for pulmonary disease
4,441
Unique beneficiaries
$94
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~347 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)1,430$95$163
Hospital follow-up visit, high complexity836$96$140
Remote patient monitoring device, 30 days661$37$86
Critical care, first 30-74 min638$172$339
Office visit, established patient (20-29 min)451$62$115
Test to determine lung volumes using gas dilution or washout449$33$73
Test to examine how well the lungs exchange gases449$42$98
Test to measure expiratory airflow and volume291$20$62
New patient office visit (45-59 min)238$124$250
Test to measure expiratory airflow and volume changes before and after medication administration162$29$107
Evaluation of use of breathing device162$13$30
Sleep study in sleep lab (6 years or older)128$460$1,100
Sleep study in sleep lab with continuous airway pressure (6 years or older)126$484$1,200
Initial hospital admission, high complexity115$131$217
Office visit, established patient, complex (40-54 min)113$143$220
Test for exercise-induced lung stress79$26$51
Test to measure oxygen level in blood using ear or finger device continuously overnight54$18$63
Sleep study including heart rate, breathing, and sleep time42$111$217
Smoking and tobacco use intensive counseling, 4-10 minutes39$15$20
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)27$29$50
New patient office visit, complex (60-74 min)23$169$315
Aspiration of initial secretion of lung airway using an endoscope22$112$332
Telephone medical discussion with physician, 21-30 minutes20$58$164
Office visit, established patient (10-19 min)19$31$70
Telephone medical discussion with physician, 11-20 minutes13$27$113
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation13$63$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,267
Total received (2018-2024)
Avg $1,610/year across 7 years
Top 18% in FL for pulmonary disease
45
Companies
597
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,267 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,307
2023
$1,633
2022
$1,281
2021
$1,331
2020
$916
2019
$2,189
2018
$1,610

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$2,243
AstraZeneca Pharmaceuticals LP
$1,888
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,601
Mylan Specialty L.P.
$740
Takeda Pharmaceuticals U.S.A., Inc.
$600
Grifols USA, LLC
$590
Sunovion Pharmaceuticals Inc.
$504
Actelion Pharmaceuticals US, Inc.
$405
Insmed, Inc.
$392
Regeneron Healthcare Solutions, Inc.
$204
United Therapeutics Corporation
$173
Amgen Inc.
$168
Paratek Pharmaceuticals, Inc.
$152
Genentech USA, Inc.
$131
Covidien LP
$120
Fisher & Paykel Healthcare Inc
$117
Ethicon Inc.
$95
Bayer Healthcare Pharmaceuticals Inc.
$93
Bayer HealthCare Pharmaceuticals Inc.
$88
Electromed, Inc.
$80
Baxter Healthcare
$79
GENZYME CORPORATION
$72
Gilead Sciences, Inc.
$68
ANI Pharmaceuticals, Inc.
$62
Circassia Pharmaceuticals Inc
$51
Shire North American Group Inc
$49
Novartis Pharmaceuticals Corporation
$49
Advanced Respiratory, Inc
$44
JAZZ PHARMACEUTICALS INC.
$38
ADVANCED RESPIRATORY, INC
$31
La Jolla Pharmaceutical Company
$31
Mallinckrodt Hospital Products Inc.
$30
Axsome Therapeutics, Inc.
$30
Avadel CNS Pharmaceuticals, LLC
$28
Ambu Inc.
$26
Merck Sharp & Dohme LLC
$26
BOSTON SCIENTIFIC CORPORATION
$24
Vapotherm Inc
$24
Merck Sharp & Dohme Corporation
$20
Inogen, Inc.
$19
Philips Electronics North America Corporation
$18
Boston Scientific Corporation
$18
Resmed Corp
$17
Veran Medical Technologies, Inc.
$15
CSL Behring
$14
Top 3 companies account for 50.9% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BREO · BREZTRI · BROVANA · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EXPECT · Esbriet · FARXIGA · FASENRA · FISHER & PAYKEL HEALTHCARE · GENERAL THROMBECTOMY · GIAPREZA · GLASSIA · Hillrom - Vest System Model 105 Home Care · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JARDIANCE · Kcentra · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · MONARCH · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · SuperDimension · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · WINREVAIR · XOLAIR · XYREM · Xolair · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $171 per 100 Medicare services performed
Looking for a pulmonary disease in Punta Gorda?
Compare pulmonary diseases in the Punta Gorda area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary Diseases within 10 mi
10
Per 100K population
5.1
County median income
$66,154
Nearest hospital
SHOREPOINT HEALTH PUNTA GORDA
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Monge is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Monge experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Monge performed 1,430 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Monge receive payments from pharmaceutical companies?
Yes. Dr. Monge received a total of $11,267 from 45 companies across 597 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Monge's costs compare to other pulmonary diseases in Punta Gorda?
Dr. Monge's average Medicare payment per service is $94. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Monge) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →